International Journal of Applied Research
Vol. 1, Issue 4, Part G (2015)
Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) in patients with congenital heart disease in a tertiary care teaching hospital
Aim and Objectives: Methicillin-safe Staphylococcus aureus (MRSA) colonization has been perceived as a noteworthy issue among hospitalized patients. Accessible information about predominance of MRSA among youngsters with inherent coronary illness (CHD) are insignificant. The point of the examination was to decide the pervasiveness of MRSA colonization and to recognize chance components for MRSA colonization among youngsters <19 years old with CHD admitted to a pediatric emergency unit.
Methods: Confirmation and week by week MRSA nasal observation testing was performed, and patients were stratified into six hazard bunches dependent on the Risk Adjustment for Congenital Heart Surgery-1 Method. The MRSA-colonized kids were contrasted with the MRSA non-colonized kids.
Results: Amid the 3-year contemplate period, there were 372 confirmations of kids with CHD to the PICU. Of the 372, 72 (19.4%) had no observation societies performed or had no earlier history of MRSA and were barred from further examination. Of the staying 300 confirmations, 29 (9.7%) (263 individual kids) were observed to be colonized. The mean age of the 263 kids when initially admitted to the PICU was 3.29 years (run 0.03– 18.30, middle 0.66). Age circulation was not essentially unique between the colonized and non-colonized gatherings (P = .236). Sex (P =. 667), race (P = .837), and CHD unpredictability (P = .395) were not altogether connected with colonization. The chances of being colonized if recently hospitalized were 4.42 occasions more prominent than if not recently hospitalized (95% certainty interim 1.89, 10.34).
Conclusion: Routine MRSA observation ought to be performed in patients with CHD to recognize colonized patients.
How to cite this article:
Suresh Kumar Behera, Rajesh Kumar Lenka. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) in patients with congenital heart disease in a tertiary care teaching hospital. Int J Appl Res 2015;1(4):382-385.